 |
 |
 |
 |
 |
 |
|
 |
If you cannot find an answer to your question here, feel free to Contact Us.
| 1. How do I request additional ID cards? |
 |
| You may request additional ID cards for your group through your account manager by calling him/her directly or at 888-243-6890. |
|
| [ top ] |
| 2. Do you own your mail pharmacy or do you contract that out? |
|
| Serve You owns and operates our own in-house mail order pharmacy, Serve You Direct Rx Pharmacy, located at our headquarters in Milwaukee. |
|
| [ top ] |
| 3. How do I get my prescriptions filled via your mail pharmacy? |
|
| To get your prescriptions filled by Serve You DirectRx Pharmacy, you must complete a New Order Form. |
|
| [ top ] |
| 4. How many retail pharmacies do you have in your network? |
|
| Serve You’s national network is comprised of more than 61,500 pharmacies. Custom and restricted networks can also be created. |
|
| [ top ] |
| 5. How often are renewal reports generated? |
|
Plan Renewal Analysis reports are generated once each year, 90 days prior to the plan renewal date. Renewal reports can be generated more frequently upon request.
Plan Renewal Analysis » |
|
| [ top ] |
| 6. How often is the formulary updated? |
|
| Quarterly. |
|
| [ top ] |
| 7. What clinical capabilites does Serve You have? |
|
Serve You is able to implement a number of clinical programs, including:
o Prior authorizations
o Step therapy
o Quantity limits
o Dose optimization
o Formulary management
o OTC Drug Coverage |
|
| [ top ] |
| 8. What type of reports do you offer? |
|
| Serve You offers a number of reports. The monthly reporting package includes an Executive Summary of key information to help track pharmacy benefit trends and a Group Utilization Report. Serve You also offers Ad Hoc reporting at no additional cost and a Plan Renewal Analysis delivered to clients 90 days prior to the end of a their benefit year. For clients that would like direct access to data to develop their own reports, Serve You also offers RxTRACK Connect. |
|
| [ top ] |
|
 |
|
 |
 |
 |
 |
 |
|
 |
 |
|
